Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018.

ABSTRACT:

Background & aims

Estimates of disease burden can inform national health priorities for research, clinical care, and policy. We aimed to estimate health care use and spending among gastrointestinal (GI) (including luminal, liver, and pancreatic) diseases in the United States.

Methods

We estimated health care use and spending based on the most currently available administrative claims from commercial and Medicare Supplemental plans, data from the GI Quality Improvement Consortium Registry, and national databases.

Results

In 2015, annual health care expenditures for gastrointestinal diseases totaled $135.9 billion. Hepatitis ($23.3 billion), esophageal disorders ($18.1 billion), biliary tract disease ($10.3 billion), abdominal pain ($10.2 billion), and inflammatory bowe

SUBMITTER: Peery AF 

PROVIDER: S-EPMC6689327 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature